These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 10742975)

  • 1. Drug disposition and targeting. Transport across the blood-brain barrier.
    Rochat B; Audus KL
    Pharm Biotechnol; 1999; 12():181-200. PubMed ID: 10742975
    [No Abstract]   [Full Text] [Related]  

  • 2. [Blood plasma proteins and drug transport across the hemato-encephalic barrier].
    Lutsevich AN; Bender KI; Kupchikov VV
    Farmakol Toksikol; 1991; 54(1):70-6. PubMed ID: 1860509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of drug transporters at the blood-brain barrier.
    Fricker G; Miller DS
    Pharmacology; 2004 Apr; 70(4):169-76. PubMed ID: 15001817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug transport studies using quantitative microdialysis.
    Dai H; Elmquist WF
    Methods Mol Med; 2003; 89():249-64. PubMed ID: 12958425
    [No Abstract]   [Full Text] [Related]  

  • 5. Functional characterization and comparison of the outer blood-retina barrier and the blood-brain barrier.
    Steuer H; Jaworski A; Elger B; Kaussmann M; Keldenich J; Schneider H; Stoll D; Schlosshauer B
    Invest Ophthalmol Vis Sci; 2005 Mar; 46(3):1047-53. PubMed ID: 15728564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolutionary combinatorial chemistry, a novel tool for SAR studies on peptide transport across the blood-brain barrier. Part 2. Design, synthesis and evaluation of a first generation of peptides.
    Teixidó M; Belda I; Zurita E; Llorà X; Fabre M; Vilaró S; Albericio F; Giralt E
    J Pept Sci; 2005 Dec; 11(12):789-804. PubMed ID: 15942930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual-targeting topotecan liposomes modified with tamoxifen and wheat germ agglutinin significantly improve drug transport across the blood-brain barrier and survival of brain tumor-bearing animals.
    Du J; Lu WL; Ying X; Liu Y; Du P; Tian W; Men Y; Guo J; Zhang Y; Li RJ; Zhou J; Lou JN; Wang JC; Zhang X; Zhang Q
    Mol Pharm; 2009; 6(3):905-17. PubMed ID: 19344115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood-brain barrier genomics and the use of endogenous transporters to cause drug penetration into the brain.
    Pardridge WM
    Curr Opin Drug Discov Devel; 2003 Sep; 6(5):683-91. PubMed ID: 14579518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generic fast gradient liquid chromatography/tandem mass spectrometry techniques for the assessment of the in vitro permeability across the blood-brain barrier in drug discovery.
    Chu I; Liu F; Soares A; Kumari P; Nomeir AA
    Rapid Commun Mass Spectrom; 2002; 16(15):1501-5. PubMed ID: 12125028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Putative proteins involved in manganese transport across the blood-brain barrier.
    Fitsanakis VA; Piccola G; Marreilha dos Santos AP; Aschner JL; Aschner M
    Hum Exp Toxicol; 2007 Apr; 26(4):295-302. PubMed ID: 17615110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Organic anion transporters.
    Tsuji A; Tamai I
    Pharm Biotechnol; 1999; 12():471-91. PubMed ID: 10742985
    [No Abstract]   [Full Text] [Related]  

  • 12. Targeted delivery across the blood-brain barrier.
    Gaillard PJ; Visser CC; de Boer AG
    Expert Opin Drug Deliv; 2005 Mar; 2(2):299-309. PubMed ID: 16296755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How to measure drug transport across the blood-brain barrier.
    Bickel U
    NeuroRx; 2005 Jan; 2(1):15-26. PubMed ID: 15717054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developmental aspects of blood-brain barrier (BBB) and rat brain endothelial (RBE4) cells as in vitro model for studies on chlorpyrifos transport.
    Yang J; Aschner M
    Neurotoxicology; 2003 Aug; 24(4-5):741-5. PubMed ID: 12900088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delivery of peptide and protein drugs over the blood-brain barrier.
    Brasnjevic I; Steinbusch HW; Schmitz C; Martinez-Martinez P;
    Prog Neurobiol; 2009 Apr; 87(4):212-51. PubMed ID: 19395337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional characterisation of nucleoside transport in rat brain endothelial cells.
    Chishty M; Begley DJ; Abbott NJ; Reichel A
    Neuroreport; 2003 May; 14(7):1087-90. PubMed ID: 12802208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug transporters in the central nervous system: brain barriers and brain parenchyma considerations.
    Lee G; Dallas S; Hong M; Bendayan R
    Pharmacol Rev; 2001 Dec; 53(4):569-96. PubMed ID: 11734619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug transport across the blood-brain barrier. II. Experimental techniques to study drug transport.
    Van Bree JB; De Boer AG; Danhof M; Breimer DD
    Pharm Weekbl Sci; 1992 Dec; 14(6):338-48. PubMed ID: 1475172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro models for the blood-brain barrier.
    Garberg P; Ball M; Borg N; Cecchelli R; Fenart L; Hurst RD; Lindmark T; Mabondzo A; Nilsson JE; Raub TJ; Stanimirovic D; Terasaki T; Oberg JO; Osterberg T
    Toxicol In Vitro; 2005 Apr; 19(3):299-334. PubMed ID: 15713540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood-brain barrier drug targeting: the future of brain drug development.
    Pardridge WM
    Mol Interv; 2003 Mar; 3(2):90-105, 51. PubMed ID: 14993430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.